|
Wellmune Research - Older Adults Last Updated: 02/23/2023 |
Wellmune® Reduced the Number of Upper Respiratory Tract Infections and the Number of Symptom Days in Older Adults Study Protocol This study aimed to test whether Wellmune® can prevent the occurrence or reduce the severity of upper respiratory tract infection (URTI) and modulate innate immune responses during winter months in community dwelling older adults. This was a double-blind placebo-controlled trial of community-dwelling adults aged 50 to 70 years randomised to once daily Wellmune® 250 mg (n=50) or identical placebo capsule (n=50) over 90 days during winter. URTI episodes were medically-confirmed. Blood and saliva samples were collected at days 0, 45 and 90 for measurements of innate immune parameters. Results
Fuller R, Moore MV, Lewith G, Stuart BL, Ormiston RV, Fisk
HL, Noakes PS, Calder PC. (2017) Yeast-Derived Beta 1,3/1,6 Glucan,
Upper Respiratory Tract Infection and Innate Immunity in Older
Adults. Nutrition 39-40:30-35. Tags:
Wellmune, Immune Health Basics, Kerry International, Beta Glucan, Beta 1, 3D Glucan, Wellmune Beta Glucan, Glucan 300
|